Profound Medical Corp. (PRN:CA) Discusses First Clinical Outcomes and Precision of TULSA ...

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
The Lancet

Familial confounding and causal inference in child and adolescent neurodevelopment and ...

Recent announcements by the US Government linking paracetamol use during pregnancy to autism in offspring highlight the risks of misinterpreting observational research to inform policy; this is a ...
Chiang Rai Times

AI Revolutionizes FDA Approval for Rare Disease Patients

FDA introduced a new "Plausible Mechanism Framework." Under this policy, certain gene therapies and RNA-based treatments ...
UroToday

OPTIMAS Trial: Testing Intermittent Therapy in Metastatic Hormone-Sensitive Prostate Cancer ...

Umang Swami presents the OPTIMAS phase 2 randomized trial for metastatic hormone-sensitive prostate cancer evaluating treatment de-intensification. Patients receive relugolix plus ...